MedTrace Logo

InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer

NCT04842916 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-11-21

No results posted yet for this study

Summary

Multicentric, exploratory, non-pharmacologic, retrospective/prospective, translational study aiming to identify the molecular, cellular and psychological-sociological variables predictive of response to chemotherapy in gastric cancer patients.

Conditions

Sponsors & Collaborators

  • ERA PERMED

    collaborator UNKNOWN

  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

    lead OTHER

Principal Investigators

  • Chiara Molinari · IRST IRCCS

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-22
Primary Completion
2027-05-22
Completion
2027-05-22

Countries

  • France
  • Greece
  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04842916 on ClinicalTrials.gov